Ponazuril (

INN Inns are generally establishments or buildings where travelers can seek lodging, and usually, food and drink. Inns are typically located in the country or along a highway; before the advent of motorized transportation they also provided accommo ...

), sold by Merial, Inc., now part of

Boehringer Ingelheim C.H. Boehringer Sohn AG & Co. is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical ...

, under the trade name Marquis® (15% w/w ponazuril), is a drug currently approved for the treatment of

equine protozoal myeloencephalitis Equine protozoal myeloencephalitis (EPM), is a disease caused by the apicomplexan parasite '' Sarcocystis neurona'' that affects the central nervous system of horses. History EPM was first discovered in the 1960s by the American biologist Dr. Ji ...

(EPM) in horses, caused by

coccidia Coccidia (Coccidiasina) are a subclass of microscopic, spore-forming, single-celled obligate intracellular parasites belonging to the apicomplexan class Conoidasida. As obligate intracellular parasites, they must live and reproduce within an a ...

'' Sarcocystis neurona''. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats, dogs, and rabbits against coccidia as an intestinal parasite. Coccidia treatment in small animals is far shorter than treatment for EPM.

References

Equine medications Diphenyl ethers Benzosulfones Trifluoromethyl compounds Isocyanuric acids {{Veterinary-med-stub

See also

References